Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner
Open accessAbstract
In the present study it was investigated whether apolipoprotein (apoE) can inhibit the lipoprotein lipase (LPL)-mediated hydrolysis of very-low-density-lipoprotein (VLDL) triacylglycerols (TAGs). Previous studies have suggested such an inhibitory role for apoE by using as a substrate for LPL either plasma VLDL or artificial TAG emulsions. To mimic the in vivo situation more fully, we decided to investigate the effect of apoE on the LPL-mediated TAG hydrolysis by using VLDL from apoE-deficient mice that had been enriched with increasing amounts of apoE. Furthermore, since plasma VLDL isolated from apoE-deficient mice was relatively poor in TAGs and strongly enriched in cholesterol as compared with VLDL from wild-type mice, we used nascent VLDL obtained by liver perfusions. Nascent VLDL (d < 1.006) isolated from the perfusate of the apoE-deficient mouse liver was rich in TAGs. Addition of increasing amounts of apoE to apoE-deficient nascent VLDL effectively decreased TAG lipolysis as compared with that of apoE-deficient nascent VLDL without the addition of apoE (63.1±6.3 and 20.8±1.8% of the control value at 2.7 μg and 29.6 μg of apoE/mg of TAG added respectively). Since, in vivo, LPL is attached to heparan sulphate proteoglycans (HSPG) at the endothelial matrix, we also performed lipolysis assays with LPL bound to HSPG in order to preserve the interaction of the lipoprotein particle with the HSPG-LPL complex. In this lipolysis system a concentration-dependent decrease in the TAG lipolysis was also observed with increasing amounts of apoE on nascent VLDL, although to a lesser extent than with LPL in solution (72.3±3.6% and 56.6±1.7% of control value at 2.7μg and 29.6 μg of apoE/mg TAGs added respectively). In conclusion, the enrichment of the VLDL particle with apoE decreases its suitability as a substrate for LPL in a dose-dependent manner.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The insufficiency of LPL appears to result from inhibition of this enzyme by apoE, which accumulates in VLDL/IDL/LDL-size lipoprotein particles.
“As reported previously ( 36,37 ), the insuffi ciency of LPL appears to result from inhibition of this enzyme by apoE, which accumulates in VLDL/IDL/LDL-size lipoprotein particles.”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [36]
Table 4 and the Discussion show that adding apoE to nascent VLDL inhibits LPL-mediated triacylglycerol hydrolysis in vitro. The Discussion treats the physiological importance of this inhibition as unresolved; it does not establish that apoE accumulation in VLDL/IDL/LDL-size particles causes LPL insufficiency. Page numbers are not available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 2
- Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V. and Brown, M. S. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 5810-5814
- Williamson, R., Lee, D., Hagaman, J. and Maeda, N. (1992) Proc. Natl. Acad. Sci. USA. 89, 7134-7138
Cited by
Sorted by citations
Mahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447 · see citing works
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
Renee Ruhaak, L., van der Laarse, A., & Cobbaert, C. M. (2019) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563219827620 · Cited by 38 · see citing works
Vezeridis, A. M., Drosatos, K., & Zannis, V. I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m008409 · Cited by 11 · see citing works
Fotakis, P., Vezeridis, A., Dafnis, I., Chroni, A., Kardassis, D., & Zannis, V. I. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048348 · Cited by 4 · see citing works
- Authors
- JONG, C. M., DAHLMANS, E. H. V., HOFKER, H. M., & HAVEKES, M. L.
- Affiliations
- Netherlands Organisation for Applied Scientific Research (NL)
- MGC-Department of Human Genetics, Leiden University, P.O. Box 9503, 2300 RA Leiden, The Netherlands
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1997-12-15
- Volume
- 328
- Issue
- 3
- Pages
- 745-750
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1218981
- OpenAlex
- W1856179322
- Cited by
- 55
- References
- 0
- Citations by year
- 2021: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- TNO Repository (submittedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- apolipoprotein E, lipoprotein lipase, VLDL, lipolysis, lipolysis inhibition, ApoE-deficient mice, heparan sulfate proteoglycans, lipoprotein metabolism
- MeSH terms
- Animals, Apolipoproteins E, Cholesterol, Electrophoresis, Polyacrylamide Gel, Lipids, Lipolysis, Lipoprotein Lipase, Lipoproteins, VLDL, Liver, Mice, Inbred Strains, Triglycerides, Mice, Knockout, Heparan Sulfate Proteoglycans, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review